Contrast Enhanced MRI of the Prostate

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

December 12, 2018

Study Completion Date

December 12, 2018

Conditions

Prostatic Neoplasms

Trial Locations (1)

Advanced Imaging Research Center, OHSU, Portland

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT02245282 - Contrast Enhanced MRI of the Prostate | Biotech Hunter | Biotech Hunter